Skip to main content

NorthRock Partners, LLC

SEC CIK
0001632097
Latest filing
Aug 11, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by NorthRock Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
16,191
Value
$1.46M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of EW by NorthRock Partners, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202616,191$1.46M<0.1%+153+1.0%AddedHolders
Q1 202616,038$1.28M<0.1%−567−3.4%ReducedHolders
Q4 202516,605$1.42M<0.1%−8,922−35.0%ReducedHolders
Q3 202525,527$1.99M<0.1%+2,822+12.4%AddedHolders
Q2 202522,705$1.78M<0.1%+2,650+13.2%AddedHolders
Q1 202520,055$1.45M<0.1%−42−0.2%ReducedHolders
Q4 202420,097$1.49M<0.1%+2,040+11.3%AddedHolders
Q3 202418,057$1.19M<0.1%−1,991−9.9%ReducedHolders
Q2 202420,048$1.85M0.1%+757+3.9%AddedHolders
Q1 202419,291$1.84M0.1%+640+3.4%AddedHolders
Q4 202318,651$1.42M0.1%+5,149+38.1%AddedHolders
Q3 202313,502$935.4K0.1%−1,154−7.9%ReducedHolders
Q2 202314,656$1.38M0.2%−527−3.5%ReducedHolders
Q1 202315,183$1.26M0.1%+958+6.7%AddedHolders
Q4 202214,225$1.06M0.1%−1,220−7.9%ReducedHolders
Q3 202215,445$1.28M0.1%−595−3.7%ReducedHolders
Q2 202216,040$1.52M0.2%+1,753+12.3%AddedHolders
Q1 202214,287$1.68M0.2%−2,757−16.2%ReducedHolders
Q4 202117,044$2.21M0.2%+383+2.3%AddedHolders
Q3 202116,661$1.89M0.2%+824+5.2%AddedHolders
Q2 202115,837$1.64M0.1%−1,346−7.8%ReducedHolders
Q1 202117,183$1.44M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.